Qiongxian Long1, Yong Peng2, Zhirong Tang1, Cailiang Wu1. 1. Department of Pathology Nanchong Central Hospital, North Sichuan Medical University Nanchong 637000, Sichuan, China. 2. Department of Gynecology and Obstetrics Nanchong Central Hospital, North Sichuan Medical University Nanchong 637000, Sichuan, China.
Abstract
OBJECTIVE: To identify patients with endometrial cancer with potential Lynch-related DNA mismatch repair (MMR) protein expression defects and to explore the role of these defects in screening for LS. METHODS: Endometrial cancers from 173 patients recruited to the Nanchong Central Hospital were tested for MMR (MLH1, MSH2, PMS2, and MSH6) protein expression using immunohistochemistry (IHC). RESULTS: In the 173 tumor tissue samples, the expression loss rates of MSH6, MSH2, PMS2 and MLH1 protein were 16.18% (28/173), 12.14% (21/173), 7.51% (13/173) and 5.78% (10/173), respectively. The total loss rate of MMR protein was 29.89% (27/87). There were 19 patients with a family history of cancer, of which 18 patients demonstrated loss of expression of MMR protein. In the 22 abnormal MMR patients without family history, five families were found to have Lynch-associated cancer (colorectal cancer, endometrial cancer, ovarian cancer, stomach cancer) after follow-up for two years. CONCLUSION: MMR proteins play an important role in the progress of endometrial cancer. The routine testing of MMR proteins in endometrial cancer can contribute to the screening of LS families, especially small families.
OBJECTIVE: To identify patients with endometrial cancer with potential Lynch-related DNA mismatch repair (MMR) protein expression defects and to explore the role of these defects in screening for LS. METHODS:Endometrial cancers from 173 patients recruited to the Nanchong Central Hospital were tested for MMR (MLH1, MSH2, PMS2, and MSH6) protein expression using immunohistochemistry (IHC). RESULTS: In the 173 tumor tissue samples, the expression loss rates of MSH6, MSH2, PMS2 and MLH1 protein were 16.18% (28/173), 12.14% (21/173), 7.51% (13/173) and 5.78% (10/173), respectively. The total loss rate of MMR protein was 29.89% (27/87). There were 19 patients with a family history of cancer, of which 18 patients demonstrated loss of expression of MMR protein. In the 22 abnormal MMR patients without family history, five families were found to have Lynch-associated cancer (colorectal cancer, endometrial cancer, ovarian cancer, stomach cancer) after follow-up for two years. CONCLUSION: MMR proteins play an important role in the progress of endometrial cancer. The routine testing of MMR proteins in endometrial cancer can contribute to the screening of LS families, especially small families.
Entities:
Keywords:
HNPCC; Lynch syndrome; endometrial cancer; immunohistochemistry; mismatch repair protein
Authors: Heather Hampel; Wendy Frankel; Jenny Panescu; Janet Lockman; Kaisa Sotamaa; Daniel Fix; Ilene Comeras; Jennifer La Jeunesse; Hidewaki Nakagawa; Judith A Westman; Thomas W Prior; Mark Clendenning; Pamela Penzone; Janet Lombardi; Patti Dunn; David E Cohn; Larry Copeland; Lynne Eaton; Jeffrey Fowler; George Lewandowski; Luis Vaccarello; Jeffrey Bell; Gary Reid; Albert de la Chapelle Journal: Cancer Res Date: 2006-08-01 Impact factor: 12.701
Authors: H J Järvinen; M Aarnio; H Mustonen; K Aktan-Collan; L A Aaltonen; P Peltomäki; A De La Chapelle; J P Mecklin Journal: Gastroenterology Date: 2000-05 Impact factor: 22.682
Authors: Johnathan M Lancaster; C Bethan Powell; Noah D Kauff; Ilana Cass; Lee-May Chen; Karen H Lu; David G Mutch; Andrew Berchuck; Beth Y Karlan; Thomas J Herzog Journal: Gynecol Oncol Date: 2007-11 Impact factor: 5.482
Authors: Karen H Lu; John O Schorge; Kerry J Rodabaugh; Molly S Daniels; Charlotte C Sun; Pamela T Soliman; Kristin G White; Rajyalakshmi Luthra; David M Gershenson; Russell R Broaddus Journal: J Clin Oncol Date: 2007-10-09 Impact factor: 44.544
Authors: Heather Hampel; Jenny Panescu; Janet Lockman; Kaisa Sotamaa; Daniel Fix; Ilene Comeras; Jennifer LaJeunesse; Hidewaki Nakagawa; Judith A Westman; Thomas W Prior; Mark Clendenning; Albert de la Chapelle; Wendy Frankel; Pamela Penzone; David E Cohn; Larry Copeland; Lynne Eaton; Jeffrey Fowler; Janet Lombardi; Patti Dunn; Jeffrey Bell; Gary Reid; George Lewandowski; Luis Vaccarello Journal: Cancer Res Date: 2007-10-01 Impact factor: 12.701
Authors: Hee Jung An; Kwang Il Kim; Ji Young Kim; Jeong Youn Shim; Haeyoun Kang; Tae Heon Kim; Jin Kyung Kim; Jeongmi Kim Jeong; Sun Young Lee; Seung Jo Kim Journal: Am J Surg Pathol Date: 2007-06 Impact factor: 6.394
Authors: Anne M Mills; Sofia Liou; James M Ford; Jonathan S Berek; Reetesh K Pai; Teri A Longacre Journal: Am J Surg Pathol Date: 2014-11 Impact factor: 6.394